51720-37-7

Basic information

• Product Name: Imidazo[1,5-c]pyrimidinium, 5,6,7,8-tetrahydro-2-methyl-5-oxo-, iodide
• Synonyms: 2-methyl-5-oxo-5,6,7,8-tetrahydroimidazo[1,5-c]pyrimidinium iodide
• CAS NO: 51720-37-7
• Molecular Formula: C7H10N3O.I
• Molecular Weight: 279.07800
• Mol File: 51720-37-7.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: Imidazo[1,5-c]pyrimidinium, 5,6,7,8-tetrahydro-2-methyl-5-oxo-, iodide(CAS DataBase Reference)
• NIST Chemistry Reference: Imidazo[1,5-c]pyrimidinium, 5,6,7,8-tetrahydro-2-methyl-5-oxo-, iodide(51720-37-7)
• EPA Substance Registry System: Imidazo[1,5-c]pyrimidinium, 5,6,7,8-tetrahydro-2-methyl-5-oxo-, iodide(51720-37-7)

Safety Data

• Hazardous Substances Data: 51720-37-7(Hazardous Substances Data)

Upstream product

• 51-45-6 histamine 
• 51-45-6 histamine 
• 14509-66-1 5,6,7,8-tetrahydro-5-oxoimidazo[1,5-c]pyrimidine 
• 74-88-4 methyl iodide 

Downstream Products

• 177268-67-6 N-α-(methoxycarbonyl)-1-methylhistamine 
• 64403-25-4 3-methyl-3,4,6,7-tetrahydro-5H-imidazo<4,5-c>pyridine 
• 501-75-7 N₁-methylhistamine 

Relevant articles and documents

2-(1H-Imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chain variants of the IGF-1R inhibitor BMS-536924

A series of IGF-1R inhibitors is disclosed, wherein the (m-chlorophenyl)ethanol side chain of BMS-536924 (1) is replaced with a series of 2-(1H-imidazol-4-yl)ethanamine and 2-(1H-pyrazol-1-yl)ethanamine side chains. Some analogs show improved IGF-1R poten

A Heteroditopic Hexa-imidazole 'Encapsulating' Podand and a Facially Differentiated Hexadentate Ligand

Syntheses of the facially differentiated tris-imidazole triamine (10) and of the novel 'hetero'-ditopic hexa-imidazole ligand (11), from histamine (3), are described.